<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/><title>
</title>
<style type="text/css">
			.cs2E86D3A6{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.cs5925EB86{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:bold;font-style:normal;}
			.cs95E872D0{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.csDD5E5F52{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:normal;}
			.cs80D9435B{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.csED7826F6{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:14pt;font-weight:bold;font-style:italic;}
			.csDA99B56C{text-align:justify;text-indent:-108pt;margin:0pt 0pt 0pt 108pt}
			.csA16174BA{color:#000000;background-color:transparent;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;}
			.cs9224F58F{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.csC970676{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.cs41ED3027{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.csE3E0FE0B{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:italic;}
			.csD15247B9{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}
			.csF0A1D375{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}
			.cs2C11128C{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:12pt;font-weight:normal;font-style:normal;}
		</style>
</head>
<body>
<p class="cs2E86D3A6"><span class="cs5925EB86">HR 8  - AS INTRODUCED</span></p><p class="cs2E86D3A6"><span class="cs5925EB86"> </span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">2021 SESSION</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	21-0182</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	06/05</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs80D9435B" style="tab-stops:left 86.45pt left 180pt;"><span class="csDD5E5F52">HOUSE RESOLUTION	</span><span class="csED7826F6">8</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csDA99B56C"><span class="csDD5E5F52">A RESOLUTION	</span><a name="bkTitleDraft0"><span class="csDD5E5F52">requesting an investigation on whether opioids, benzodiazepines, and exposure to chemical agents contribute to suicides by veterans.</span></a></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csDA99B56C" style="tab-stops:left 108pt;"><span class="csDD5E5F52">SPONSORS:	Rep. Abramson, Rock. 37; Rep. Greeson, Graf. 16; Rep. Ankarberg, Straf. 10</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csDA99B56C" style="tab-stops:left 108pt;"><span class="csDD5E5F52">COMMITTEE:	State-Federal Relations and Veterans Affairs</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csA16174BA">-----------------------------------------------------------------</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">ANALYSIS</span></p><p class="cs2E86D3A6"><span class="csDD5E5F52"> </span></p><p class="cs9224F58F" style="tab-stops:left 18pt left 86.45pt;"><span class="csDD5E5F52">	This resolution requests that the United States Congress, the Department of Defense, and the Veterans Administration investigate whether opioids, benzodiazepines, and exposure to agent orange contribute to a higher rate of suicides by veteran members of the armed forces.</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0"><span class="csDD5E5F52">- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - </span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csC970676" style="tab-stops:left 13.5pt left 81.4pt left 94.5pt;"><span class="csDD5E5F52"> </span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	21-0182</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	06/05</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">STATE OF NEW HAMPSHIRE</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">In the Year of Our Lord Two Thousand Twenty One</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="csDA99B56C"><span class="csDD5E5F52">A RESOLUTION	</span><a name="bkTitleDraft1"><span class="csDD5E5F52">requesting an investigation on whether opioids, benzodiazepines, and exposure to chemical agents contribute to suicides by veterans.</span></a></p><p class="csD15247B9"><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="cs2C11128C"> </span><span class="csDD5E5F52">Whereas, in fiscal 2012, the Veterans Administration issued benzodiazepines to 28 percent of the 640,000 veterans seen for post traumatic stress disorder (PTSD), and the amount of prescriptions at the Veterans Administration for these drugs amounted to 2.4 million in fiscal 2014; and</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	Whereas, 27 percent of veterans who received opioid analgesics from 2004-2009 also received benzodiazepines; and</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	Whereas, benzodiazepines can be addictive and can possibly enhance fear following trauma and suicidal thoughts, they also have some valid uses, such as stopping panic attacks from escalating, easing sleep disorders, and helping agitated patients at high risk of harm to themselves or others; and </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	Whereas, the 2015 suicide rate for female veterans receiving care through the Veterans Health Administration was 17.8 per 100,000, compared to 45.6 male veterans under care; and</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	Whereas, the Department of Veterans Affairs now reports that the New Hampshire veterans suicide rate of 33 per year was, "significantly higher than the national suicide rate;" and</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	Whereas, 20.6 armed service veterans are taking their own lives each day, substantially higher than the national average, with the suicide rate for veterans aged 18-34 increased substantially to 45 deaths per 100,000; and</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	Whereas, while the Veterans Administration's clinical practice guidelines recommend against their use in patients with PTSD due to "lack of efficacy data and growing evidence for the potential risk of harm," physicians often prescribe them to patients who come to them already taking those medications because abruptly stopping them can incur serious risks; and</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	Whereas, the suicide rate among veterans ages 18 to 27 receiving care at VA medical facilities is 79 per 100,000, and suicide rates among armed service veterans receiving care has been substantially higher than among those not under care; now, therefore, be it</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	Resolved by the House of Representatives:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	That the New Hampshire general court respectfully urges the Congress of the United States, the Department of Defense, and the Department of Veterans Affairs to investigate whether opioids, benzodiazepines, exposure to agent orange,  insecticides,  pyridostigmine bromide, and nerve agents including, but not limited to, sarin and cyclosarin, as well as vaccines administered to military personnel such as Mefloquine, and constant, long term stress from service in the theater of operations are contributing to the high number of suicides by veteran members of the armed forces; and </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	That the house clerk forward official copies of this resolution to the President of the United States, the Speaker of the United States House of Representatives, the President of the United States Senate, the Secretary of Defense, the Secretary of Veterans Affairs, and to all the members of the New Hampshire congressional delegation with the request that this resolution be officially entered in the Congressional Record as a high priority for the Congress of the United States of America.</span></p></body>
</html>
